Cargando…
Pharmacological treatment of chorea in Huntington’s disease–good clinical practice versus evidence-based guideline
Recently, the American Academy of Neurology published an evidence-based guideline for the pharmacological treatment of chorea in Huntington’s disease. Although the progress in medical care because of the implementation of criteria of evidence-based medicine is undisputed, the guideline classifies th...
Autor principal: | Reilmann, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842832/ https://www.ncbi.nlm.nih.gov/pubmed/23674480 http://dx.doi.org/10.1002/mds.25500 |
Ejemplares similares
-
Update on the Non-Huntington's Disease Choreas with Comments on the Current Nomenclature
por: Walker, Ruth H.
Publicado: (2012) -
Good publication practices in clinical pharmacology: transparency, evidence-based medicine and the 7-D assessment*
por: Woodcock, Barry G., et al.
Publicado: (2015) -
Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease
por: Coppen, Emma M., et al.
Publicado: (2016) -
Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories
por: Ross, Christopher A., et al.
Publicado: (2019) -
An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington’s Disease
por: Burgunder, Jean-Marc, et al.
Publicado: (2011)